ALBIGER, NORA MARIA ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.846
AS - Asia 1.065
EU - Europa 753
SA - Sud America 172
AF - Africa 158
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.774
CN - Cina 328
SG - Singapore 323
DE - Germania 136
BR - Brasile 131
HK - Hong Kong 129
IT - Italia 101
VN - Vietnam 87
FI - Finlandia 82
SE - Svezia 69
GB - Regno Unito 63
UA - Ucraina 41
NL - Olanda 31
PL - Polonia 31
FR - Francia 30
RU - Federazione Russa 24
KR - Corea 23
AT - Austria 22
IN - India 21
IE - Irlanda 18
JP - Giappone 13
TR - Turchia 12
ES - Italia 10
MA - Marocco 10
ZA - Sudafrica 10
CO - Colombia 9
MX - Messico 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
BZ - Belize 8
CA - Canada 8
CI - Costa d'Avorio 8
GR - Grecia 8
KE - Kenya 8
AZ - Azerbaigian 7
BJ - Benin 7
BW - Botswana 7
IQ - Iraq 7
JO - Giordania 7
NC - Nuova Caledonia 7
NO - Norvegia 7
PE - Perù 7
PH - Filippine 7
TH - Thailandia 7
BF - Burkina Faso 6
DJ - Gibuti 6
ID - Indonesia 6
MD - Moldavia 6
MY - Malesia 6
NI - Nicaragua 6
PY - Paraguay 6
SA - Arabia Saudita 6
BA - Bosnia-Erzegovina 5
CH - Svizzera 5
EE - Estonia 5
GH - Ghana 5
GM - Gambi 5
HU - Ungheria 5
IL - Israele 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
LC - Santa Lucia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
RW - Ruanda 5
SD - Sudan 5
SO - Somalia 5
UY - Uruguay 5
AF - Afghanistan, Repubblica islamica di 4
AL - Albania 4
AR - Argentina 4
BY - Bielorussia 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GP - Guadalupe 4
HR - Croazia 4
KG - Kirghizistan 4
ME - Montenegro 4
MG - Madagascar 4
MK - Macedonia 4
PA - Panama 4
UZ - Uzbekistan 4
YE - Yemen 4
YT - Mayotte 4
ZW - Zimbabwe 4
AM - Armenia 3
BB - Barbados 3
BD - Bangladesh 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EC - Ecuador 3
ET - Etiopia 3
GE - Georgia 3
GN - Guinea 3
GT - Guatemala 3
LB - Libano 3
LY - Libia 3
Totale 5.906
Salva come PNG Salva come JPEG
Città #
Fairfield 571
Woodbridge 347
Chandler 334
Ashburn 330
Ann Arbor 322
Houston 252
Seattle 210
Cambridge 207
Singapore 190
Wilmington 186
Jacksonville 169
Hong Kong 123
Beijing 115
Boardman 70
Princeton 68
Dong Ket 64
Santa Clara 61
San Diego 50
Des Moines 38
Munich 34
Helsinki 29
Padova 29
Medford 28
Los Angeles 27
Nanjing 26
Frankfurt am Main 25
Hefei 25
Bytom 20
Roxbury 20
Seoul 16
Nuremberg 13
Turku 13
New York 12
Vienna 11
Dublin 10
Ho Chi Minh City 10
London 10
Nanchang 10
Milan 9
Shanghai 8
Tokyo 8
Abidjan 7
Amman 7
Athens 7
Belize City 7
Cotonou 7
Jiaxing 7
Noumea 7
San Francisco 7
San Jose 7
Shenyang 7
São Paulo 7
Zhengzhou 7
Baku 6
Brooklyn 6
Chennai 6
Djibouti 6
Falls Church 6
Florence 6
Jinan 6
Nairobi 6
Ouagadougou 6
Redwood City 6
Accra 5
Castries 5
Gaborone 5
Hanoi 5
Hebei 5
Johannesburg 5
Kigali 5
Lima 5
Managua 5
Medellín 5
Phnom Penh 5
Renton 5
Rio de Janeiro 5
Tianjin 5
Antananarivo 4
Asunción 4
Auckland 4
Bangkok 4
Banjul 4
Borås 4
Brussels 4
Changsha 4
Columbus 4
Curitiba 4
Harare 4
Indiana 4
Istanbul 4
Kunming 4
Mumbai 4
Norwalk 4
Panama City 4
San José 4
Sanaa 4
Secaucus 4
Tashkent 4
Vientiane 4
Warsaw 4
Totale 4.406
Salva come PNG Salva come JPEG
Nome #
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 226
Diagnosis and complications of Cushing's disease: gender-related differences. 196
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 177
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 176
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 174
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 172
Metyrapone treatment in Cushing’s syndrome: a real-life study 171
Early recognition of aggressive pituitary adenomas: a single-centre experience 170
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? 164
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 158
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 157
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 154
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 151
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 148
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 148
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 147
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 146
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 145
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 145
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 134
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 132
Therapeutic strategies for Cushing's syndrome: An update 130
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 130
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 128
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 127
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 126
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 126
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 125
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 122
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 122
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 118
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 117
Predicting late recurrence in surgically-treated patients with Cushing's disease. 117
Adrenal morpho-functional alterations in patients with acromegaly. 116
Effect of short term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerosis markers in hypopituitary patients with growth hormone deficiency. 115
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. 112
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 105
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 104
The role of the size in thyroid cancer risk stratification 100
Cyclic Cushing's syndrome: an overview. 95
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. 94
Aterosclerosi extra coronaria nella sindrome di Cushing 90
Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary. 77
Sindrome di Cushing e rischio cardiovascolare 73
Utilità  dell'uso dei test (DDAVP, CRH e 8 MG DEX OVERNIGHT) nell'indicazione chirurgica e nell'outcome della malattia di Cushing 70
Corticotropin-releasing hormone test predicts the outcome of unilateral adrenalectomy in primary bilateral macronodular adrenal hyperplasia 63
Totale 6.093
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.309
article - articoli 20.641
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021524 0 0 30 53 15 27 13 50 79 93 66 98
2021/2022685 14 73 82 52 63 48 18 87 28 15 63 142
2022/2023583 125 89 6 89 78 71 1 36 54 3 26 5
2023/2024267 5 39 33 14 31 30 36 12 5 7 26 29
2024/20251.101 5 50 66 56 162 33 38 85 96 47 181 282
2025/2026847 205 391 251 0 0 0 0 0 0 0 0 0
Totale 6.093